Unknown

Dataset Information

0

Disease modifying therapies and infection risks in multiple sclerosis-a decision-making conundrum.

ABSTRACT:

SUBMITTER: Yong KP 

PROVIDER: S-EPMC7327337 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Disease modifying therapies and infection risks in multiple sclerosis-a decision-making conundrum.

Yong Kok Pin KP   Kim Ho Jin HJ  

Annals of translational medicine 20200601 11

Similar Datasets

Unknown Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.
| S-EPMC7823546 | biostudies-literature
Unknown Infection Mitigation Strategies for Multiple Sclerosis Patients on Oral and Monoclonal Disease-Modifying Therapies.
| S-EPMC8132488 | biostudies-literature
Unknown Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
| S-EPMC8013440 | biostudies-literature
Unknown Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies.
| S-EPMC9234852 | biostudies-literature
Unknown Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.
| S-EPMC10755740 | biostudies-literature
Unknown Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection.
| S-EPMC9306262 | biostudies-literature
Unknown Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies.
| S-EPMC6965059 | biostudies-literature
Unknown Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review.
| S-EPMC8940867 | biostudies-literature
Unknown COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
| S-EPMC7980129 | biostudies-literature
Unknown Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches.
| S-EPMC6183038 | biostudies-literature